| Basics |
Boston Scientific Corp.
Boston Scientific Corp is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
|
| IPO Date: |
January 3, 1994 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$137.42B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.33 | 1.22%
|
| Avg Daily Range (30 D): |
$1.12 | 1.13%
|
| Avg Daily Range (90 D): |
$0.98 | 0.97%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
9.89M |
| Avg Daily Volume (30 D): |
7.03M |
| Avg Daily Volume (90 D): |
7.12M |
| Trade Size |
| Avg Trade Size (Sh.): |
252 |
| Avg Trade Size (Sh.) (30 D): |
70 |
| Avg Trade Size (Sh.) (90 D): |
71 |
| Institutional Trades |
| Total Inst.Trades: |
103,796 |
| Avg Inst. Trade: |
$3.26M |
| Avg Inst. Trade (30 D): |
$12.98M |
| Avg Inst. Trade (90 D): |
$11.21M |
| Avg Inst. Trade Volume: |
.11M |
| Avg Inst. Trades (Per Day): |
18 |
| Market Closing Trades |
| Avg Closing Trade: |
$27.2M |
| Avg Closing Trade (30 D): |
$149.56M |
| Avg Closing Trade (90 D): |
$134.6M |
| Avg Closing Volume: |
695.1K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$1.88
|
$.51
|
$.54
|
|
Diluted EPS
|
$1.87
|
$.51
|
$.53
|
|
Revenue
|
$ 19.35B
|
$ 5.07B
|
$ 5.06B
|
|
Gross Profit
|
$ 13.27B
|
$ 3.54B
|
$ 3.42B
|
|
Net Income / Loss
|
$ 2.78B
|
$ 755M
|
$ 795M
|
|
Operating Income / Loss
|
$ 3.46B
|
$ 1.05B
|
$ 819M
|
|
Cost of Revenue
|
$ 6.08B
|
$ 1.52B
|
$ 1.64B
|
|
Net Cash Flow
|
$ -1173M
|
$ 735M
|
$ -178M
|
|
PE Ratio
|
0.00
|
|
|
|
|
|
